Replies to post #3030 on Antares Pharma, Inc. (ATRS)

[Bsav88atty]

If LaRoux's comment of "I'd be happy with 15% market share" becomes a reality, that's $750M of a projected $5B market.

Let that quote sink in for awhile...I'd say with $200M or more from peak sales from Otrexup and $750M from QST, perhaps my $1B by 2018 is not too far fetched after all.

Thanks to Jab for the transcript and to TD and the others for the follow-on commentary.

In my opinion, ATRS remains a topnotch longterm investment.

Best of luck to all the longs here.